Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome.
Vicente A, Patel BA, Gutierrez-Rodrigues F, Groarke E, Giudice V, Lotter J, Feng X, Kajigaya S, Weinstein B, Barranta E, Olnes MJ, Parikh AR, Albitar M, Wu CO, Shalhoub R, Calvo KR, Townsley DM, Scheinberg P, Dunbar CE, Young NS, Winkler T.
Vicente A, et al. Among authors: scheinberg p.
Haematologica. 2020 Dec 1;105(12):2785-2794. doi: 10.3324/haematol.2020.249995.
Haematologica. 2020.
PMID: 33256377
Free PMC article.